These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2405169)

  • 21. Clinical data on the antitumor activity of hydrazine sulfate.
    Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
    Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydrazine sulfate in nonsmall-cell lung cancer.
    Gold J
    J Clin Oncol; 1990 Jun; 8(6):1117-8. PubMed ID: 2161450
    [No Abstract]   [Full Text] [Related]  

  • 23. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
    Loprinzi CL; Goldberg RM; Su JQ; Mailliard JA; Kuross SA; Maksymiuk AW; Kugler JW; Jett JR; Ghosh C; Pfeifle DM
    J Clin Oncol; 1994 Jun; 12(6):1126-9. PubMed ID: 8201374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic and biologic therapies in cancer care: Part II.
    Decker GM
    Clin J Oncol Nurs; 2000; 4(6):283-4, 287. PubMed ID: 11899327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent acquisitions in cancer chemotherapy].
    Amiel JL; Bernard J; Bessis M; Dreyfus B; Najean Y; Seligmann M; Péquignot H
    Presse Med (1893); 1966 Jun; 74(32):1683-6. PubMed ID: 5935822
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Gold J
    Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 'grand conspiracy' against the cancer cure.
    Regelson W
    JAMA; 1980 Jan; 243(4):337-9. PubMed ID: 6985983
    [No Abstract]   [Full Text] [Related]  

  • 28. More about: biology of cachexia.
    Gold J
    J Natl Cancer Inst; 1998 Jul; 90(14):1101-2. PubMed ID: 9672260
    [No Abstract]   [Full Text] [Related]  

  • 29. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydrazine sulfate and preneoplastic exfoliated cells.
    Norman RL
    Oncology; 1975; 32(5-6):221-2. PubMed ID: 1228537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecule of the month. Elesclomol and obatoclax mesylate.
    Drug News Perspect; 2008 Mar; 21(2):123-4. PubMed ID: 18389103
    [No Abstract]   [Full Text] [Related]  

  • 32. 1-acetyl-2-picolinoylhydrazine (NSC-68626) in the treatment of advanced cancer.
    Olson KB; Horton J; Pratt KL; Paladine WJ; Cunningham T; Sullivan J; Hosley H; Treble DH
    Cancer Chemother Rep; 1969 Oct; 53(5):291-6. PubMed ID: 5377616
    [No Abstract]   [Full Text] [Related]  

  • 33. Procarbazine (NSC-77213) in the treatment of advanced bronchogenic carcinoma.
    Samuels ML; Leary WV; Howe CD
    Cancer Chemother Rep; 1969 Apr; 53(2):135-45. PubMed ID: 4895098
    [No Abstract]   [Full Text] [Related]  

  • 34. Current pharmacological management of anorexia in cancer patients.
    Bruera E
    Oncology (Williston Park); 1992 Jan; 6(1):125-30; discussion 132, 137. PubMed ID: 1531597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experiences with a methylhydrazine derivative (Natulan)].
    Hertz H; Hansen MM; Videbaek AA
    Ugeskr Laeger; 1966 Mar; 128(11):316-24. PubMed ID: 5331015
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical observations on the short-term effects of a synthetic antiblastic agent, a derivative of methylhydrazine, with or without radiotherapy].
    Massenti S; Perri G
    Minerva Radiol; 1967 Apr; 12(4):140-4. PubMed ID: 5613803
    [No Abstract]   [Full Text] [Related]  

  • 37. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydrazine sulfate ad is "offensive".
    Jenks S
    J Natl Cancer Inst; 1993 Apr; 85(7):528-9. PubMed ID: 8455198
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism of hydrazine anti-cancer agents.
    Tweedie DJ; Erikson JM; Prough RA
    Pharmacol Ther; 1987; 34(1):111-27. PubMed ID: 3310042
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of a methyl hydrazine derivative in the treatment of Hodgkin's disease].
    Hollard D; Schaerrer R
    Lyon Med; 1966 Apr; 215(17):1167-74. PubMed ID: 5930371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.